A two-member NCLAT bench observed the lenders of Mittal Corp were “empowered to issue fresh RFRP” when none of the resolution plans had been approved by the committee of creditors (CoC). NCLAT said issues raised by Jindal Stainless subsequent to February 10, 2023, when RFRP was issued, need no consideration.
Moderna shares soar 135% in a day after cancer vaccine succeeds in late-stage trial
Moderna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, reduced melanoma recurrence and spread significantly. This